Bengt Gustavsson, member

Bengt Gustavsson, born 1962, has a MSc in Pharmacy and a PhD in Pathalogy (tumour biology)
from Uppsala university and a certificate in Pharmaceutical Medicine from the University of
Basel. Bengt has 27 years´ experience from the pharmaceutical industry and has primarily been
working with Clinical Development and Medical Affairs in different cancer indications. He has
held positions such as Nordic Medical Director at Novartis Oncology, Nordic Clinical Research
Director at Sanofi-Aventis, Nordic Medical Director at Celgene, and lately as Senior Global Medical
Affairs Director at Oncopeptides AB. Bengt is a board member of Nanexa AB and Sangus Jazz AB and a previous

Other assignments: Board member Nanexa AB and Sangus Jazz AB.

Shareholdings: –